Pharmapress Co 20.0mg/12.5 mg Tablet
PDF Leaflet Revision Date: 03 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of hypertension where fixed combination therapy is preferred.
Dosage (summary)
1 tablet daily, may increase to 2 tablets if needed.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may harm fetus.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- Fluoroquinolones
Contraindications
- Hypersensitivity to components
- History of angioedema
- Severe renal impairment
- Bilateral renal artery stenosis
Common side effects
- Hypotension
- Cough
- Dizziness
Counselling Points
- Monitor blood pressure regularly.
- Report any signs of angioedema.
- Avoid potassium supplements.
Serious warnings
- Risk of angioedema
- Monitor renal function
- Hypotension risk in heart failure
Important Disclaimer
The Pharmapress Co 20.0mg/12.5 mg Tablet professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
